Using in vivo high-resolution positron emission tomographic imaging and postmortem autoradiography derived from patients’ samples, the authors showed decreased levels of synaptic vesicle glycoprotein 2A (SV2A) in PD patients (Matuskey et al., 2020). This evidence concerns the gene SV2A and Parkinson disease.